Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2941 to 2955 of 7685 results

  1. Myocardial infarction: PCI rates (IND74)

    This indicator covers the time between call for help and balloon inflation for patients with ST segment elevation myocardial infarction (STEMI) undergoing reperfusion by primary percutaneous coronary intervention (PCI). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG93

  2. Myocardial infarction: PCI in less than 60 minutes (IND73)

    This indicator covers the proportion of patients with ST-segment elevation myocardial infarction (STEMI) who had balloon inflation for primary percutaneous coronary intervention (PCI) in less than 60 minutes from time of admission at a centre with primary PCI facilities. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG92

  3. Myocardial infarction: coronary reperfusion (IND72)

    This indicator covers the proportion of patients with ST-segment elevation myocardial infarction (STEMI) who had coronary reperfusion therapy. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG91

  4. Pregnancy: 10-week booking appointment (IND62)

    This indicator covers proportion of pregnant women accessing antenatal care who are seen for booking by 10 weeks and 0 days. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG81

  5. Cancer: stage at diagnosis recorded (IND2)

    This indicator covers the proportion of new cases of cancer with stage at diagnosis recorded. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG02

  6. Stroke and ischaemic attack: mortality within 30 days (IND28)

    This indicator covers mortality rates within 30 days of hospital admission for stroke. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG45

  7. Executive team

    Biographies of the NICE executive team and minutes of their meetings

  8. Cancer: breast cancer mortality rate (IND4)

    This indicator covers breast cancer mortality rates (female). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG04

  9. Cancer: breast screening (53 to 70 years) (IND65)

    This indicator covers the proportion of women aged 53 to 70 years whose record shows a breast screening test has been performed within the last 3 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG84

  10. Highly specialised technologies evaluation committee

    Our recommendations on the use of highly specialised technologies are made by an independent advisory committee. This is called the highly specialised

  11. Policies and procedures

    Our policies and procedures on topics including declarations of interest, gifts and hospitality, complaints, and more.

  12. Guidance executive

    Guidance Executive

  13. Bringing our guidance together by topic

    We're bringing our guidance together by topic, so that it's all in one place, clearer to understand and easier to access. We expect that this will...

  14. Our research work

    NICE's research work and partnerships with researchers, funders, charities and policy organisations.

  15. Structure of NICE

    Our board sets out our strategic priorities and policies. The day to day decision-making is the responsibility of our executive team . The...